Charles Explorer logo
🇬🇧

Synergy of an antihypertensive and a hypolipidemic treatment - the search with a happy ending

Publication at First Faculty of Medicine |
2020

Abstract

The determination of cardiovascular risk and its intervention became a routine of physicians in the first line of specialists. With regards to importance and prevalence in the population, the most significant risk factors of aterosclerotic circulation diseases are blood pressure and dyslipidemia.

While the control of the first one is gradually improving, the number of patients with dyslipidemia reaching target values in the categories with the highest risk is decreasing. Of course, also as a result of newly introduced guidelines that redefined optimal values of aterogenic lipids again.

The question of whether current level of cardiovascular risk control can be improved and how remains unanswered. There are several opportuinities for improvement: influencing non-adherence, therapeutic inertia, improving the utilization of current treatment options.

We can expect their widening in the future. The change of intervention strategy offers another chance that uses the synergy of current treatment options, more risk factors and the factor of treatment timing according to the principle 'the longer lower, the better'.